静脉注射免疫球蛋白对川崎病患儿中性粒细胞的影响

Abstract
Figure/Table
References(10)
Related Citation (15)
Read Tracking
Download Tracking

	［1］Ayusawa M, Sonobe T, Uemura S, Nakamura Y, Ogawa S, Kiyosawa N. Revision of diagnostic guidelines for Kawasaki disease(the 5th revised edition)［J］. Pediatr Int, 2005, 47(2): 232-234.
	［2］Esper F, Shapiro ED, Weibel C, Ferguson D, Landry ML, Kahn JS. Association between a novel human coronavirus and Kawasaki disease［J］. J Infect Dis, 2005, 191(4): 499-502.
	［3］Yeung RSM. The etiology of Kawasaki disease: a superantigen-mediated process［J］. Prog Pediatr Cardiol, 2004, 19(2): 115-122.
	［4］Yeung RS. Pathogenesis and treatment of Kawasaki's disease［J］. Curr Opin Rheumatol, 2005, 17(5): 617-623.
	［5］胡景伟，杨凌，郑承宁，王琨蒂，王萍，周忠蜀.川崎病并发冠状动脉病变的临床特点［J］.中国当代儿科杂志，2010，12（3）：228-230.
	［6］Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease［J］. J Pediatr, 1992, 121(6): 924-926.
	［7］Igarashi H, Hatake K, Tomizuka H, Yamada M, Gunji Y, Momoi MY. High serum level of M-CSF and G-CSF in Kawasaki disease［J］. Br J Hematol, 1999, 105(3): 613-615.
	［8］Suzuki H, Noda E, Miyawaki M, Takeuchi T, Uemura S, Koike M. Serum levels of neutrophil activation cytokines in Kawasaki disease［J］.Pediatr Int, 2001, 43(2): 115-119.
	［9］Onouchi Z, Hamaoka K, Ozawa S, Sakata K, Kiyosawa N, Ito H. Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm［J］. Pediatr Int, 2009, 51(4): 448-452.
	［10］Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I.Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease［J］.Clin Immunol, 2002,103(2): 161-168.